Nonagase, Y., Yonesaka, K., Kawakami, H., Watanabe, S., Haratani, K., Takahama, T., . . . Tsurutani, J. (2016). Heregulin-expressing HER2-positive breast and gastric cancer exhibited heterogeneous susceptibility to the anti-HER2 agents lapatinib, trastuzumab and T-DM1. Oncotarget.
Citação norma ChicagoNonagase, Yoshikane, et al. "Heregulin-expressing HER2-positive Breast and Gastric Cancer Exhibited Heterogeneous Susceptibility to the Anti-HER2 Agents Lapatinib, Trastuzumab and T-DM1." Oncotarget 2016.
Citação norma MLANonagase, Yoshikane, et al. "Heregulin-expressing HER2-positive Breast and Gastric Cancer Exhibited Heterogeneous Susceptibility to the Anti-HER2 Agents Lapatinib, Trastuzumab and T-DM1." Oncotarget 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.